T-cell receptor architecture and clonal tiding provide insight into the transformation trajectory of peripheral T-cell lymphomas

被引:2
|
作者
Willscher, Edith [1 ]
Schultheiss, Christoph [2 ,3 ]
Paschold, Lisa [1 ]
Schuemann, Franziska Lea [1 ]
Schmidt-Barbo, Paul [2 ]
Thiele, Benjamin [2 ,3 ]
Bauer, Marcus [4 ]
Wickenhauser, Claudia [4 ]
Weber, Thomas
Binder, Mascha [2 ,3 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Internal Med 4, Oncol Hematol, Halle, Germany
[2] Univ Basel, Dept Biomed Translat Immuno Oncol, Basel, Switzerland
[3] Univ Hosp Basel, Div Med Oncol, Basel, Switzerland
[4] Martin Luther Univ Halle Wittenberg, Dept Pathol, Halle, Germany
关键词
TRANSCRIPTION FACTORS; REPERTOIRE; TET2; DIFFERENTIATION; MANAGEMENT; DISEASE; DNMT3A;
D O I
10.3324/haematol.2024.285395
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
While T-cell lymphomas are classified as mature neoplasms, emerging evidence indicates that malignant transformation may occur at an earlier stage of T-cell maturation. In this study, we determined clonal architecture in a broad range of T-cell lymphomas. Our multidimensional profiling indicates that many of these lymphomas do in fact emerge from an immature lymphoid T-cell precursor at a maturation stage prior to V(D)J rearrangement that undergoes branching evolution. Consequently, at single-cell resolution we observed considerable clonal tiding under selective therapeutic pressure. T-cell receptor next-generation sequencing suggested a highly biased usage of TRBV20-1 gene segments as part of multiple antigen receptor rearrangements per patient. The predominance of TRBV20-1 was found across all major T-cell lymphoma subtypes analyzed. This suggested that this particular V gene - independently of complementarity-determining region 3 configuration - may represent a driver of malignant transformation. Together, our data indicate that T-cell lymphomas are derived from immature lymphoid precursors and display considerable intratumoral heterogeneity that may provide the basis for relapse and resistance in these hard-to-treat cancers.
引用
收藏
页码:457 / 469
页数:13
相关论文
共 50 条
  • [41] ABERRANT PHENOTYPES IN PERIPHERAL T-CELL LYMPHOMAS
    HASTRUP, N
    RALFKIAER, E
    PALLESEN, G
    JOURNAL OF CLINICAL PATHOLOGY, 1989, 42 (04) : 398 - 402
  • [42] PATHOLOGY OF PERIPHERAL T-CELL LYMPHOMAS AND LEUKEMIAS
    WATANABE, S
    HEMATOLOGICAL ONCOLOGY, 1986, 4 (01) : 45 - 58
  • [43] Novel therapies in peripheral T-cell lymphomas
    O'Leary H.M.
    Savage K.J.
    Current Hematologic Malignancy Reports, 2008, 3 (4) : 213 - 220
  • [44] Molecular genetics of peripheral T-cell lymphomas
    Piccaluga, Pier Paolo
    Tabanelli, Valentina
    Pileri, Stefano A.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (03) : 219 - 226
  • [45] Novel Therapies in Peripheral T-Cell Lymphomas
    O'Leary, Hilary M.
    Savage, Kerry J.
    CURRENT ONCOLOGY REPORTS, 2008, 10 (05) : 404 - 411
  • [46] THE PROGNOSTIC FACTORS FOR PERIPHERAL T-CELL LYMPHOMAS
    LIANG, R
    LOKE, SL
    CHAN, ACL
    HEMATOLOGICAL ONCOLOGY, 1992, 10 (3-4) : 135 - 140
  • [47] BELINOSTAT FOR THE TREATMENT OF PERIPHERAL T-CELL LYMPHOMAS
    McDermott, J.
    Jimeno, A.
    DRUGS OF TODAY, 2014, 50 (05) : 337 - 345
  • [48] INTENSIVE CHEMOTHERAPY FOR PERIPHERAL T-CELL LYMPHOMAS
    LIANG, R
    TODD, D
    CHAN, TK
    CHIU, E
    LIE, A
    HO, FCS
    LOKE, SL
    HEMATOLOGICAL ONCOLOGY, 1992, 10 (3-4) : 155 - 161
  • [49] Peripheral T-Cell Lymphomas: Therapeutic Approaches
    Sibon, David
    CANCERS, 2022, 14 (09)
  • [50] T-CELL LYMPHOMAS
    MIODUSZEWSKA, O
    ARCHIV FUR GESCHWULSTFORSCHUNG, 1979, 49 (08): : 685 - 693